The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-10 of 10 articles
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter R,
Hamm C,
Steg PG,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by longitudinal sequential optical coherence tomography assessments: the EGO-BIOFREEDOM study
Lee WLS,
Tam FCC,
Chan KKW,
Lam S,
Kong S-L,
Shea CP,
Wong MKL,
Wong AYT,
Yung ASY,
Zhang L-W,
Lam Y-M,
Mintz G,
Costa R,
Stoll H,
Maehara A
September 20, 2018 | 10.4244/EIJ-D-18-00061
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial
Lipiecki J,
Brunel P,
Morice M,
Roguelov C,
Walsh S,
Richardt G,
Eerdmans P,
Zambahari R,
Berland J,
Copt S,
Stoll H,
Urban P
July 20, 2018 | 10.4244/EIJ-D-18-00293
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C,
Naber C,
Urban P,
Ong P,
Valdés Chávarri M,
Abizaid A,
Pocock S,
Fabbiocchi F,
Dubois C,
Copt S,
Stoll H,
Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning A,
Abizaid A,
Bartorelli A,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong M,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley S,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II
Vaina S,
Voudris V,
Morice M,
De Bruyne B,
Colombo A,
Macaya C,
Richardt G,
Fajadet J,
Hamm C,
Schuijer M,
Macours N,
Stoll H,
Cokkinos D,
Stefanadis C,
Serruys P
January 20, 2009
Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
Serruys P,
Daemen J,
Morice M,
De Bruyne B,
Colombo A,
Macaya C,
Richardt G,
Fajadet J,
Hamm C,
Dawkins K,
Vranckx P,
Bressers M,
van Domburg R,
Schuijer M,
Wittebols K,
Pieters M,
Stoll H
January 20, 2008
Latest news
AHEAD OF PRINT
Outcomes of DES by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials
FREE ARTICLE - Tobias Rheude et al
December 1, 2022
AHEAD OF PRINT
Early pathologic responses to BP- vs DP-DES
FREE ARTICLE - Yasuhito Kawagoe et al
November 30, 2022
NEW ISSUE
PCR London Valves issue; debates on key issues; unplanned PCI after TAVR; percutaneous vascular closure strategies after TAVI; ViV-TMVR vs redo-SMVR; RV-PA coupling on TR after TEER...
November 18, 2022
AHEAD OF PRINT
Continued NOAC vs VKA in TAVI
FREE ARTICLE - Norman Mangner et al
November 28, 2022
PCR LONDON VALVES LATE BREAKING
ACURATE neo2 PMCF Study
FREE ARTICLE - Won-Keun Kim et al
November 27, 2022
AHEAD OF PRINT
TAVI with a novel system for severe pure native AR in a patient with ascending aorta aneurysm
FREE ARTICLE - Hendrik Wienemann et al
November 23, 2022
AHEAD OF PRINT
Radiation protection for pregnant healthcare professionals: an EAPCI statement
FREE ARTICLE - Stéphane Manzo-Silberman et al
November 22, 2022